Duopharma Biotech Bhd Group of Companies

Duopharma Biotech Bhd posted a 6 increase in net profit for the second quarter ended June 30 2022 to RM1631 million from RM1539 million a year earlier underpinned by a higher revenue. Its quarterly revenue jumped by nearly 17 to RM18174 million from RM15544 million fuelled by higher sales to the ethical classic market and public health.


Duopharma Biotech Berhad Linkedin


Ccm Duopharma Biotech Gets Approval For New Drug The Edge Markets


Homepage Duopharma Biotech Berhad


Duopharma Biotech Berhad Linkedin


Duopharma Biotech Invests A Total Of Us 500 000 Into Naluri S Series A Funding Round Businesstoday

No comments for "Duopharma Biotech Bhd Group of Companies"